Stocks/AVR

AVR

Anteris Technologies Global Corp.
Healthcare·Medical - Devices
$8.62
$317M market cap
Revenue
$0.8M
Free Cash Flow
$-47.6M
Rev Growth
+0.0%
FCF Margin
-5919.4%
P/FCF
--
EV/FCF
--
Fwd EV/EBITDA
--
Fair Value
--
Upside
--

Anteris Technologies Global Corp., a structural heart company, discovers, develops, and commercializes medical devices to enhance the quality of life for patients with aortic stenosis. Its lead product candidate is the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also devlops ADAPT anti-calcification tissue, an anti-calcification preparation tha

2-Year Price History

$9.62+71.8%
$3.0$4.0$5.0$6.0$7.0$8.0$9.0volDec 24Mar 25May 25Aug 25Nov 25Feb 26May 26

Quarterly Financials & Projections

Quarterly Waterfall ($ M)
PeriodRevEBITDAOpInNIOCFFCFCapExCashDebtSharesROICIntCovEV/EBITDA
Act2026-Q10.5-23.6-24.0-23.0-28.7-28.8-0.1283.23.723.6-34.0%-873.3x--
Act2025-Q40.3-28.5-29.0-29.2-18.5-18.8-0.312.62.323.6<-999%-2854.2x--

Valuation & Metrics

Market Stats

Price$8.62
Market Cap$317M
Enterprise Value$38M
P/S Ratio394.4x
P/FCF--
EV/FCF--
FCF Margin (TTM)-5919.4%
FCF Yield-15.0%
Dividend Yield (TTM)--
Annual Dilution0.0%
CurrencyUSD

TTM Financial Snapshot

Revenue$0.8M
Net Income$-52.2M
Free Cash Flow$-47.6M

Revenue Growth (YoY)+0.0%
EBITDA Margin-6482.6%
Net Margin-6495.8%
FCF Margin-5919.4%
CapEx % of Revenue47.9%
SBC % of Revenue359.7%
ROIC-2555.6%
WC Change % Rev-929.5%
Interest Coverage-1408.7x

Forward Outlook & Risk

Short Interest

Short % of Float--
Short Shares3.7M
Days to Cover5.2
Change (vs Prior)-9.5%
Need at least 2 settlement dates for chart

Employees

Headcount136
Revenue / Employee$5,912
Gross Profit / Employee$-1,860

Institutional Ownership

Headline & net flow

NEUTRAL
Net flow · still filing
No float data — flow unavailable.

Ownership composition

Active
88.7%(+65.7% YoY)
115 filers
hedge / family / endowment
Retail funds
Fidelity, Schwab, 401(k)
Passive
17.2%(+16.3% YoY)
8 filers
Vanguard, iShares, SPDR
Market makers
0.4%(+0.3% YoY)
5 filers
Citadel, Susquehanna
Insiders
Form 4 — latest per insider
0%25%50%75%100%2024-122025-032025-062025-092025-122026-03
ActiveRetail fundsPassiveMarket makersRetail direct

Top holders

Fund$ valueCost basisΔ QoQΔ YoYα lifeFund AUM
L1 Capital Pty Ltd$43.2M$4.80+$27.6M+$5.0M+2.5%$2.55B
Nantahala Capital Management, LLC$30.7M$5.44+$16.7M+$21.5M-2.4%$1.60B
Sio Capital Management, LLC$29.9M$5.55+$19.5M+$16.7M-1.1%$694M
BlackRock, Inc.Passive$27.1M$4.97+$15.9M+$24.9M-0.2%$5.69T
ADAR1 Capital Management, LLC$21.0M$5.22+$14.2M+$11.7M+8.4%$1.64B
PERCEPTIVE ADVISORS LLC$19.0M$5.57+$9.7M+$7.1M-1.4%$5.05B
RA CAPITAL MANAGEMENT, L.P.$16.7M$5.55+$16.7M+$16.7M-4.4%$9.44B
BVF INC/IL$16.7M$5.55+$16.7M+$16.7M-0.4%$3.14B
FMR LLC$16.1M$5.54+$15.9M+$16.1M-0.0%$1.89T
Ensign Peak Advisors, Inc$11.6M$5.20+$3.8M+$3.6M-0.4%$53.58B
GEODE CAPITAL MANAGEMENT, LLCPassive$10.2M$4.93+$5.8M+$9.3M+2.3%$1.61T
Rhenman & Partners Asset Management AB$8.0M$3.90+$1.1M+$825K-1.1%$784M
UBS Group AG$7.8M$5.07+$4.9M+$7.1M-0.3%$562.11B
STATE STREET CORPPassive$6.8M$5.14+$4.8M+$6.3M-0.2%$2.89T
Vestal Point Capital, LP$6.4M$5.55+$6.4M+$6.4M-0.1%$3.58B
Affinity Asset Advisors, LLC$5.1M$5.25+$2.4M+$2.9M+0.5%$1.60B
Oasis Management Co Ltd.$4.8M$5.56+$4.4M+$4.0M-3.1%$729M
VANGUARD CAPITAL MANAGEMENT LLCPassive$4.8M$5.55+$4.8M+$4.8M$4.04T
SUVRETTA CAPITAL MANAGEMENT, LLC$4.7M$5.55+$4.7M+$4.7M-9.1%$3.69B
Alyeska Investment Group, L.P.$4.2M$5.57+$1.1M+$1.1M-0.5%$35.33B
Cost basis is a volume-weighted estimate from accumulation periods within our 13F history; holders who built their position before our window started will show a stale basis. % above the cost basis is the unrealized gain at the current price.

Trading behavior

Smart-money alpha (lifetime, %/qtr)BULLISH
Holders
-0.22%
avg per quarter
Holders (ex-self)
-0.20%
excl. this stock
Buyers (this Q)
-0.39%
115 buyers · $0.26B in
Sellers (this Q)
-0.96%
9 sellers · $0.01B out
alpha coverage: 96% of $ has a lifetime-alpha record
Holder behavior on this stocksource: stock
On big dips (−10%+)
+5.1%
how holders react when this stock falls
On quiet Qs
-28.5%
−10% to +10% baseline
On rallies (+10%+)
+13.5%
how they react when this stock rises
Holders' portfolio flow this Q
+6.9%
inflows — adds are organic
Sellers' portfolio flow this Q
+26.8%
Sellers grew AUM elsewhere — opinionated cut of this stock.
▸ Compare to holder-profile behavior (across all their stocks)
Holder dip (any stock)
+0.2%
Holder mid (any stock)
-4.6%
Holder rally (any stock)
-9.0%

Top Holders Over Time

5-year share-count history (top 10 holders by peak, incl. exited) + price

09.9M19.9M29.8M39.8M$3.64$4.13$4.61$5.10$5.582024-122025-032025-062025-092025-122026-03
hover the chart for per-quarter detailprice (right axis)
L1 Capital Pty Ltd7.8MNantahala Capital Management, LLC5.5MSio Capital Management, LLC5.4MADAR1 Capital Management, LLC3.8MPERCEPTIVE ADVISORS LLC3.4MBVF INC/IL3.0MRA CAPITAL MANAGEMENT, L.P.3.0MFMR LLC2.9MEnsign Peak Advisors, Inc2.1MRhenman & Partners Asset Management AB1.4MUBS Group AG1.4M

Related Stocks

Investors who own this also own

Stocks held by the same active managers as this one, ranked by score — how much more often these appear together than random chance (1× = baseline). Excludes index ETFs and market makers; minimum 3 shared holders.

TickerNameCo-holdersScore
ABVXAbivax S.A.377.71×

Analyst Coverage

Analyst Coverage
Price Targets
Last Quarter (1 analysts)$18.0010880.0%
Last Year (2 analysts)$16.509140.0%
Current Price$8.62
Analyst Ratings
2
Buy: 2Consensus: Buy

Corporate

Insider Trading (last 12mo)

Open-market only (Form 4 P-Purchase + S-Sale). Excludes grants, option exercises, tax withholding, gifts.
Major holders (≥10% beneficial owners)
Buys ($, 12mo)
$28.75M
2 txns · 1 insider · 6,333,334 sh
Sells ($, 12mo)
$0
0 txns · 0 insiders · 0 sh
Recent transactions
DateSideInsiderTitleSharesPriceDollarsOwned $
2026-01-22BUYL1 Capital Pty Ltd10 percent owner5,000,000$5.75$28.75M$76.01M
2025-10-28BUYL1 Capital Pty Ltd10 percent owner1,333,334$0.00$0$0

Order Flow (FINRA, ~3w lag)

26.5%retail+7.5pp
19.8%dark-4.3pp
week of 2026-04-13
0%20%40%60%24-1225-0325-0525-0825-1126-0226-04retail (non-ATS)dark (ATS)
Off-exchange volume from FINRA. Retail = non-ATS (wholesaler PFOF + broker internalization). Dark = ATS (dark-pool crossing networks, institutional). Lit-exchange = remainder.

Filing Risk Analysis

Filing Risk Scores

Anteris Technologies: Massive Post-Period Dilution Masks Year-End Technical Insolvency

Overall Risk
8/10
Fraud
3/10
Dilution
10/10
Insolvency
9/10
Earnings Overstated
4/10
Hidden Liabilities
5/10
Legal
4/10
Audit Warnings
7/10
Hidden Upside
6/10
Contextually Acceptable
8/10